Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Pyrexia
ADR ID BADD_A03683
ADR Hierarchy
08      General disorders and administration site conditions
08.05      Body temperature conditions
08.05.02      Febrile disorders
08.05.02.003      Pyrexia
Description An abnormal elevation of body temperature, usually as a result of a pathologic process. [MeSH]
MedDRA Code 10037660
MeSH ID D005334; D005335
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Chills & fever | Chills and fever | Drug fever | Febrile reaction | Fever | Fever chills | Fever of unknown origin | Heat production increased | Heat retention | High temperature | Intermittent pyrexia | Periodic fever | PUO | Pyrexia | Pyrexia abnormal | Pyrexia drug | Pyrexia NOS | Pyrexia of unknown origin | Pyrexia of unknown origin (excl puerperal) | Pyrexial | Reaction febrile | Slight fever | Spiking temperature | Slight temperature | Intermittent fever | Cotton fever | Febricula | Fluctuating fever | Chronic fever | Acute febrile illness | Feverish | Pyrogenic reaction | Subfebrile | Low grade fever | Subjective fever | Fevers | Pyrexias | Hyperthermia | Hyperthermias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01577Nitrofurantoin (macrocrystals)--
BADD_D01578Nitrofurantoin (monohydrate/macrocrystals)--
BADD_D01581Nivolumab--
BADD_D01587Norfloxacin--
BADD_D01588Nortriptyline--
BADD_D01589Nortriptyline hydrochloride--
BADD_D01592Obeticholic acid--
BADD_D01593Obiltoxaximab--
BADD_D01596Ofatumumab--
BADD_D01598Ofloxacin--
BADD_D01599Olanzapine0.010546%
BADD_D01600Olanzapine pamoate--
BADD_D01601Olaparib0.003358%
BADD_D01604Olodaterol--
BADD_D01605Olopatadine--
BADD_D01606Olopatadine hydrochloride--
BADD_D01607Olsalazine--
BADD_D01608Olsalazine sodium--
BADD_D01609Omacetaxine mepesuccinate0.000862%
BADD_D01610Omalizumab--
BADD_D01614Omeprazole0.000032%
BADD_D01615Omeprazole magnesium--
BADD_D01616Onabotulinumtoxina--
BADD_D01617Ondansetron0.000247%
BADD_D01618Ondansetron hydrochloride--
BADD_D01620Oprelvekin--
BADD_D01623Oritavancin0.000797%
BADD_D01624Orlistat--
BADD_D01627Oseltamivir--
BADD_D01629Osimertinib0.004466%
The 23th Page    First    Pre   23 24 25 26 27    Next   Last    Total 36 Pages
ADReCS-Target
ADR Term Drug Name Target